SELL and B-cell chronic lymphocytic leukemia: Of the studied markers, patients with IgHVmut had a higher percentage of cells expressing CXCR3 (P = 0.003, Figure 3(a)) and CD62L (P = 0.003) in the whole population of CLL cells compared to those with IgHVunmut status.